XT
LXRX icon

XTX Topco’s Lexicon Pharmaceuticals LXRX Stock Holding History

XTX Topco’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$859K Buy
357,877
+43,263
+14% +$84.3K 0.01% 1932
2026
Q1 		$491K Buy
314,614
+218,524
+227% +$318K 0.01% 2072
2025
Q4 		$111K Sell
96,090
-233,446
-71% -$321K ﹤0.01% 2609
2025
Q3 		$445K Buy
329,536
+263,260
+397% +$299K 0.02% 1162
2025
Q2 		$62.7K Buy
66,276
+53,805
+431% +$34.9K ﹤0.01% 1979
2025
Q1 		$5.75K Buy
+12,471
New +$7.87K ﹤0.01% 2301
2024
Q4 		– Sell
-80,423
Closed -$126K – 2669
2024
Q3 		$126K Buy
+80,423
New +$143K 0.01% 1562
2021
Q2 		– Sell
-14,165
Closed -$83K – 975
2021
Q1 		$83K Buy
+14,165
New +$98.1K 0.04% 582

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

XTX Topco's LXRX Position: Q2 2026 in Review

XTX Topco increased its Lexicon Pharmaceuticals (LXRX) stake by 14% in Q2 2026, buying an estimated $84.3K and bringing the position to 357,877 shares worth $859K. The position accounts for 0.01% of the portfolio, ranked #1932.

XTX Topco first reported a position in LXRX in Q1 2021 and has held it in 8 quarters since. 148 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.

  • XTX Topco held 357,877 shares of Lexicon Pharmaceuticals worth $859K as of Q2 2026.
  • XTX Topco bought 43,263 Lexicon Pharmaceuticals shares in Q2 2026, an estimated $84.3K.
  • Lexicon Pharmaceuticals made up 0.01% of XTX Topco's portfolio in Q2 2026, its #1932 holding.
  • XTX Topco first reported a position in Lexicon Pharmaceuticals in Q1 2021 and has held it in 8 quarters since.
  • 148 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.